Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7923]

Understanding anti-cancer activity of malaria treatments

Understanding anti-cancer activity of malaria treatments

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no...

Drug combination makes cancer disappear in mice with neuroblastoma

Drug combination makes cancer disappear in mice with neuroblastoma

Difficult-to-treat bowel cancers respond in first study of new drug combination

Difficult-to-treat bowel cancers respond in first study of new drug combination

Combination of two immunotherapies shows activity in non-small cell lung cancer patients

Combination of two immunotherapies shows activity in non-small cell lung cancer patients

Two genomic tests identify groups of patients most likely to benefit from new drugs

Two genomic tests identify groups of patients most likely to benefit from new drugs

Genomics provide hope for those with 'one in a million' cancer diagnosis

Genomics provide hope for those with 'one in a million' cancer diagnosis

Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug

Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug

Solving the mystery of NPM1 in acute myeloid leukaemia

Solving the mystery of NPM1 in acute myeloid leukaemia

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

More from ecancer